Navigation Links
Pravastatin Launched by Watson Pharmaceuticals

Pravastatin sodium has been launched by Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, under a distribution agreement with Bristol-Myers Squibb Company. Shipments of pravastatin sodium tablets// have been started by Watson, in the 10, 20 and 40 mg strengths.

Watson Pharmaceuticals, Inc. has its headquarters in Corona, CA. It is a leading specialty pharmaceutical company that specializes in the development, manufacture, marketing, and distribution of brand and generic pharmaceutical products. Watson owes its remarkable growth to the company’s strategy of combining internal product development along with strategic alliances and synergistic acquisitions of products and businesses.

This Pravastatin sodium is the authorized generic version of Bristol-Myers Squibb's Pravachol(R) product. It consumption has been recommended along with the diet to decrease risks of first heart attack in patients with cardiovascular risks such as elevated cholesterol. It has also been recommended to prevent recurrent heart attack or a stroke in patients with cardiovascular disease especially when diet and exercise are not enough to reverse the symptoms of the disease.

In the year 2005 Pravachol(R) produced sales of approximately $1.7 billion, according to IMS Health data.
'"/>




Page: 1

Related medicine news :

1. Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets
2. Nutrient Profiling System Launched By Food Officials in UK
3. New Oat And Soy-Based Fat Replacer Launched
4. Race Based Genome Project Launched By Mexico
5. Action Plan Against Drug Deaths Launched
6. New Fund Launched To Help HIV Positive Women
7. Use Of Viread Spreads As New Anti-AIDS Site Is Launched
8. Erectile Dysfunction Drug Viagra Launched In India By Pfizer
9. Unique Smoking Helpline Launched In Manchester
10. Unique Smoking Helpline Launched In Manchester
11. New Home-Fertility Kit Launched For Men

Post Your Comments:
(Date:11/25/2009)... CAMBRIDGE, Mass. -- A cancer vaccine carried int...ized implant is the first to successfully eliminat...n the journal Science Translational Medicine . ,...immunologists at Harvard University, uses plastic ... implanted under the skin to reprogram the mammali...
(Date:11/25/2009)... Nationwide Imaging Servi... organizations for diagnostic imaging equipment, n...ent, including financing options, service and inst...(dba Atlas Medical Technologies of California) , ... 25, 2009 -- Nationwide Imaging Services is proud ...
(Date:11/25/2009)...,, MT.CLEMENS,Mich.,Nov.25/PRNewswire/--Twomo...ec.3andSaturday,Dec.5,theMacombCountyHealthDepartm...bothtakeplaceatFreedomHillCountyParkinSterlingHeig...;theDec.5onewillrunfrom9a.m.to3p.m.Thethimerosol-f...nrequest,whilesupplieslast.Bothinjectableandnasals...
(Date:11/25/2009)... , HOUSTON - Two signaling pathways essential to ...and epidermal growth factor receptor (EGFR) pathwa...invasion and metastasis, researchers from The Univ...t in the Nov. 25 issue of Molecular Cell . , Th...signaling components known to correlate with invas...
(Date:11/25/2009)... This release is available in French . , ... by McGill University Health Centre researchers ha...urs. The new approach is an immunotherapy customiz...by Dr. J-P. Routy from the Research Institute of t...e Universit de Montral. "This is a vaccine made fo...
Breaking Medicine News(10 mins):Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 3Health News:Macomb County Health Department Schedules Two More H1N1 Flu Vaccine Clinics Dec. 3 and 5 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 3Health News:Tailor-made HIV/AIDS treatment closer to reality 2
...searchers from the University of Pennsylvania Scho...arch in Germany have found that two drugs bind to ...at the same time, suggesting the possibility of a ...factor receptors (EGFR) sitting on their surface a...
...ve Screening of Newborns Vulnerable for Rare,Metab...elly, former,Buffalo Bills quarterback who led the... Capitol Hill on Tuesday, April 8, 2008, to meet w... with Senators Christopher,Dodd and Hillary Clinto...
...., April 8, 2008 New,study results released today...(ASDS) show the top procedures performed by dermas...surgeries., According to the 2007 Procedure Surve...,446/year, -- Laser and Light Treatment - 1,359,3...
..., 2008 Nonin Medical, Inc., in an,effort to addre...remote,monitoring, unveiled the world,s first fing...at the American Telemedicine Association (ATA) mee...he,emerging Medical Device Profile (MDP), IEEE1107...
...08 Rising Medical Solutions, Inc.,(Rising), a nat...orkCompEDI, an electronic transaction clearinghous...process electronic billing transactions,between he...y contracted with WorkCompEDI to implement a natio...
... April 8, 2008 Diplomat Specialty,Pharmacy today ...irector of,National Accounts. Maynard reports dire...ed Markets., Maynard is responsible for the devel... Diplomat,s disease,management programs, through d...
Other Medicine News:Health News:Double binding sites on tumor target may provide future combination therapy 2Health News:Pro Football Hall of Fame Member Jim Kelly Urges Congress to Approve the Newborn Screening Saves Lives Act 2Health News:Pro Football Hall of Fame Member Jim Kelly Urges Congress to Approve the Newborn Screening Saves Lives Act 3Health News:Pro Football Hall of Fame Member Jim Kelly Urges Congress to Approve the Newborn Screening Saves Lives Act 4Health News:The American Society for Dermatologic Surgery Releases New Procedure Survey Data 2Health News:Advancing Interoperability - Nonin(R) Medical Unveils World's First Bluetooth(R)-Enabled, Wireless Fingertip Pulse Oximeter 2Health News:Rising Medical Solutions and WorkCompEDI Establish Relationship to Provide Workers' Compensation eBilling Solutions 2Health News:Rising Medical Solutions and WorkCompEDI Establish Relationship to Provide Workers' Compensation eBilling Solutions 3Health News:Diplomat Specialty Pharmacy Hires National Accounts Director To Expand Kidney Disease Services 2
(Date:11/25/2009)...sResearchGroup,Inc.releasedWave1ofits LaunchTrend...ndicatedmarketresearchprojecttrackingthelaunchofCe...ughthefirstsixmonthsofavailability.Eachwaveofthere...matologistsandqualitativeinformationfromasubsetof2...use,typicalpatienttypes,productperceptions,promoti...
(Date:11/25/2009).../--AMPACFineChemicalsLLC(AFC),asubsidiaryofAmerica...atitreceivedtheEnvironmentalResponsibilityandSusta...mit,sponsoredbytheCaliforniaManufacturersandTechno...sociation(IEA)andtheChemicalIndustryCouncilofCalif...awardavailablefromallthreeorganizationsandgainssub...
(Date:11/25/2009)...er.comannouncesthatanewmarketresearchreportisavail...GlobalMarketPerspective ,, http://www.report...al-Market-Perspective.html ,, Risingincidenceo...ionsisaprincipalfactorinfluencinggrowthinthemammog...tcancerhasallowedwomentocomeforwardfortheiryearlym...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Alan Weinstein Named Chairman of PerfectServe Advisory Board 57479 1Alan Weinstein Named Chairman of PerfectServe Advisory Board 57479 2J D Power and Associates Reports 3A Among Pharmacy Customers Satisfaction is Equally as High for the Privately Insured and for Those With Public Pri 57477 1J D Power and Associates Reports 3A Among Pharmacy Customers Satisfaction is Equally as High for the Privately Insured and for Those With Public Pri 57477 2J D Power and Associates Reports 3A Among Pharmacy Customers Satisfaction is Equally as High for the Privately Insured and for Those With Public Pri 57477 3J D Power and Associates Reports 3A Among Pharmacy Customers Satisfaction is Equally as High for the Privately Insured and for Those With Public Pri 57477 4J D Power and Associates Reports 3A Among Pharmacy Customers Satisfaction is Equally as High for the Privately Insured and for Those With Public Pri 57477 5J D Power and Associates Reports 3A Among Pharmacy Customers Satisfaction is Equally as High for the Privately Insured and for Those With Public Pri 57477 6J D Power and Associates Reports 3A Among Pharmacy Customers Satisfaction is Equally as High for the Privately Insured and for Those With Public Pri 57477 7DynaVox Mayer Johnson Receives Microsoft Award 57475 1DynaVox Mayer Johnson Receives Microsoft Award 57475 2
...poration,(Nasdaq: DNDN ) today announced publicat...n investigational active cellular immunotherapy, i...ncology. The article highlights,the safety profile...E in,women with HER2/neu-positive breast cancer wh...emonstrating that NEUVENGE was safe and well,toler...
...X: HBP /Frankfurt: WKN,918864) , ,AURORA, ON, ...earch,at Helix BioPharma Corp., a developer of nov...tific poster at the Fourth International,Conferenc... 6th to,10th in Florence, Italy. , ,The confer...ronment,Society, is a premier gathering of interna...
Other Medicine Technology:Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients 2Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients 3Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients 4Helix Biopharma to Present L-DOS47 Lung Cancer Research Findings at,the Fourth International Conference on Tumor Microenvironment in,Florence, Italy 2Helix Biopharma to Present L-DOS47 Lung Cancer Research Findings at,the Fourth International Conference on Tumor Microenvironment in,Florence, Italy 3Helix Biopharma to Present L-DOS47 Lung Cancer Research Findings at,the Fourth International Conference on Tumor Microenvironment in,Florence, Italy 4
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
Medicine Products: